2026 has been a landmark year for celiac disease research. Three Phase 2 clinical trials are showing promising results for drugs that allow celiacs to consume gluten without intestinal damage. A new blood test can now detect celiac disease in its earliest stages, before significant damage occurs. Researchers have also identified specific gut bacteria profiles that correlate with celiac disease severity, opening the door for probiotic interventions. While a cure remains years away, these developments represent real progress toward a future where accidental gluten exposure is no longer a medical emergency.
#celiac#research#medical#breakthrough
